Clinical studies recruiting near Villejuif

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Gustave Roussy · Eli Lilly and Company · NCT07218380 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Gustave Roussy · Pfizer · NCT07028853 Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric
Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris · Institut Curie · NCT05439005 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Gustave Roussy · Bristol-Myers Squibb · NCT07106762 Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Phase 2/Phase 3 · The p53abn-RED trial: Institute Gustave Roussy · Leiden University Medical Center · NCT05255653 Assessment the sExual Quality of Life in Breast Cancer Patients Receiving oncoSexology Supportive Care on Proactive Vers
NA · Institut Gustave Roussy · Institut du Cancer de Montpellier - Val d'Aurelle · NCT06415266 Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endo
Phase 3 · Gustave Roussy · Gustave Roussy, Cancer Campus, Grand Paris · NCT06712472 A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · Gustave Roussy · Pfizer · NCT07206225 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · Gustave Roussy Institute - Service pharmacie · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 Clearance of Vasoactive Metabolites With Blood Purification
Phase N/A · Hôpital Paul Brousse · Assistance Publique - Hôpitaux de Paris · NCT06109142 Gustave Roussy Cancer Profiling
NA · Gustave Roussy Cancer Campus Grand Paris · Gustave Roussy, Cancer Campus, Grand Paris · NCT04932525 Efficacy of a Video-Based Educational Program on Female Urinary Incontinence
NA · Mme GRUYER DROUET Laurence - Kinésithérapeute - 7 Rue Jean B · Poitiers University Hospital · NCT07105150 Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer
Phase 2 · Gustave Roussy · Center Eugene Marquis · NCT05265208 A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuva
Phase 3 · Gustave Roussy · Gustave Roussy, Cancer Campus, Grand Paris · NCT06781996 Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · Gustave Roussy · CellCentric Ltd. · NCT04068597 TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Phase N/A · Institut Gustave Roussy · NovoCure Ltd. · NCT06924099 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
Phase 1/Phase 2 · Institut Gustave Roussy · Centre Leon Berard · NCT07243470 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Institut Gustave Roussy · Hospices Civils de Lyon · NCT05444712 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · Institut Gustave Roussy /ID# 258460 · AbbVie · NCT06109272 Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management
Phase 2 · Gustave Roussy · SOLTI Breast Cancer Research Group · NCT07371585 Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete
NA · Gustave Roussy · Institut Curie · NCT04731610 Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
Phase 1/Phase 2 · Institut Gustave Roussy · OSE Immunotherapeutics · NCT05751798 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Gustave Roussy · Eli Lilly and Company · NCT06890598 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Institute Gustave Roussy · Turning Point Therapeutics, Inc. · NCT03093116 Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Gra
Phase 2 · Institut Gustave Roussy · Centre Leon Berard · NCT03624244 Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
Phase 1/Phase 2 · Gustave ROUSSY · Centre Oscar Lambret · NCT05384821 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Gustave Roussy · Regeneron Pharmaceuticals · NCT06091865 A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-
Phase 1 · Gustave Roussy · Regeneron Pharmaceuticals · NCT05685173 Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
NA · Gustave Roussy · Gustave Roussy, Cancer Campus, Grand Paris · NCT06813573

Look up another city

Look up another condition